Publications
Publications
Show Results For
- All HBS Web
(5,747)
- Faculty Publications (1,324)
- 2024
- Book
Deals: The Economic Structure of Business Transactions
By: Guhan Subramanian and Michael Klausner
Drawing on real-life cases from a wide range of industries, two acclaimed experts offer a sophisticated but accessible guide to business deals, designed to maximize value for your side.
Business transactions take widely varying forms—from multibillion-dollar... View Details
Business transactions take widely varying forms—from multibillion-dollar... View Details
- 2024
- Article
Half the Firms, Double the Profits: Public Firms' Transformation, 1996–2022
By: Mark J. Roe and Charles C.Y. Wang
The number of public firms in the United States has halved since the beginning of the twenty-first century, causing consternation among corporate and securities law regulators. The dominant explanations, often advanced by Securities and Exchange commissioners when... View Details
- February 15, 2024
- Article
What Does Banning Short-Term Rentals Really Accomplish?
By: Sophie Calder-Wang, Chiara Farronato and Andrey Fradkin
Concerns that short-term rentals fueled by platforms like Airbnb have caused long-term rents to rise in major cities has caused some governments to place limits, including bans, on them. But research of New York City found that short-term rentals are not the biggest... View Details
- February 2024
- Case
Tabby: Winning Consumers' Digital Wallets
By: Eva Ascarza and Fares Khrais
Hosam Arab (MBA 2009), cofounder and CEO of Tabby, a Saudi-based fintech startup, raised its Series D funding round in October 2023, four years after its inception, valuing it as a regional unicorn. Tabby's core product, a buy-now-pay-later (BNPL) service, allowed... View Details
- February 2024
- Article
An Economic Framework for Vaccine Prioritization
By: Mohammad Akbarpour, Eric Budish, Piotr Dworczak and Scott Duke Kominers
We propose an economic framework for determining the optimal allocation of a scarce supply of vaccines that become gradually available during a public health crisis, such as the Covid-19 pandemic. Agents differ in observable and unobservable characteristics, and the... View Details
- February 2024
- Case
Compass Pathways: Pioneering Psychedelic Treatment
By: Tiona Zuzul, Kisha Lashley and Gamze Yucaoglu
This case follows Compass Pathways, a pioneering company developing treatment for depression based on psilocybin, the compound found in ‘magic mushrooms.’ Psilocybin was a federally illegal substance in the U.S., and a “Schedule I” drug, defined as a drug “with no... View Details
- February 2024
- Case
FIGS: Scrubbing the Status Quo
By: Jeffrey F. Rayport and Nicole Tempest Keller
In October 2023, FIGS had revolutionized the medical scrubs industry with its fashionable and functional designs, but the venture was at a critical juncture. The digitally native vertical brand (DNVB) had gone public in a successful IPO in 2021 and reached $500 million... View Details
- February 2024
- Article
Pricing Power in Advertising Markets: Theory and Evidence
By: Matthew Gentzkow, Jesse M. Shapiro, Frank Yang and Ali Yurukoglu
Existing theories of media competition imply that advertisers will pay a lower price in equilibrium to reach consumers who multi-home across competing outlets. We generalize, extend, and test this prediction. We find that television outlets whose viewers watch more... View Details
- 2025
- Working Paper
Who Values Democracy?
By: Max Miller
This paper examines the conventional view that redistribution is central to the democratization process using data from stock markets. Consistent with this view, democratizations have a large, negative impact on asset valuations driven by a rise in redistribution risk.... View Details
- January 2024 (Revised June 2024)
- Case
Equal Justice Initiative: Mercy, Truth and Dignity
By: V. Kasturi Rangan, Gerald Chertavian and Brittany Logan
In 1989, the Equal Justice Initiative was established as a non-profit, public interest law firm by Harvard Law School graduate, Bryan Stevenson.
EJI provides legal assistance to condemned prisoners, people wrongly convicted or unfairly sentenced, children in... View Details
EJI provides legal assistance to condemned prisoners, people wrongly convicted or unfairly sentenced, children in... View Details
- January 2024 (Revised June 2024)
- Case
School of Rock: Tuning into Structured Empowerment (A)
By: Tatiana Sandino, Jeffrey Rayport, Samuel Grad and Stacy Straaberg
In summer 2021, School of Rock was a youth-oriented music education company with 291 franchise- and company-owned schools globally. Before CEO Rob Price’s hire in 2017, School of Rock’s nonconformist rock ‘n’ roll culture led to variability in teaching styles,... View Details
Keywords: Business Growth and Maturation; Business Plan; Change Management; Transformation; Communication Strategy; Decisions; Curriculum and Courses; Teaching; Employee Relationship Management; Knowledge Sharing; Leadership Style; Business or Company Management; Growth and Development Strategy; Management Style; Marketing Strategy; Mission and Purpose; Organizational Change and Adaptation; Organizational Culture; Organizational Structure; Franchise Ownership; Performance Expectations; Performance Improvement; Strategic Planning; Attitudes; Conflict Management; Corporate Strategy; Applications and Software; Technology Adoption; Education Industry; Music Industry; Massachusetts; United States
- January 11, 2024
- Article
Understanding the Tradeoffs of the Amazon Antitrust Case
By: Chiara Farronato, Andrey Fradkin, Andrei Hagiu and Dionne Lomax
Regulators in the United States and Europe have been taking on Big Tech, challenging what they say are the companies’ anti-competitive and predatory strategies that harm consumers and third-party users of their platforms. This article examines the FTC’s case against... View Details
- January 2024
- Article
Cost of Exempting Sole Orphan Drugs from Medicare Negotiation
By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome
Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details
Objective: To estimate Medicare spending and global... View Details
- January 2024
- Article
Dog Eat Dog: Balancing Network Effects and Differentiation in a Digital Platform Merger
By: Chiara Farronato, Jessica Fong and Andrey Fradkin
Digital platforms are increasingly the subject of regulatory scrutiny. In comparison to multiple competitors, a single platform may increase consumer welfare if network effects are large or may decrease welfare due to higher prices or reduction in platform variety. We... View Details
- December 12, 2023
- Article
Prices for Common Services at Quaternary vs Nonquaternary Hospitals
By: Brandon W. Yan, Maximilian J. Pany and Leemore S. Dafny
Using commercial health insurance claims data from 2017-2019, we assessed whether quaternary hospitals charged higher prices for common, unspecialized services also offered by nonquaternary hospitals. We found quaternary-hospital price premiums of 8.2 percent, on... View Details
- December 2023
- Background Note
Organizational Learning
By: Willy Shih
This is a background note that surveys part of the extensive literature on organizational learning. The focus is on learning from experiences, how those learnings get translated into organizational routines and processes, and how that can also lead to getting stuck in... View Details
- December 2023
- Article
What Can Stockouts Tell Us About Inflation? Evidence from Online Micro Data
By: Alberto Cavallo and Oleksiy Kryvtsov
We use a detailed micro dataset on product availability and stockouts to construct a direct high-frequency measure of consumer product shortages during the 2020-2022 pandemic. We document a widespread multi-fold rise in stockouts in nearly all sectors early in the... View Details
- November 2023 (Revised April 2024)
- Case
BiomX: Bringing Phage Back to the Stage
By: Paul A. Gompers, Elie Ofek, Orna Dan and Emilie Billaud
In the spring of 2023, and following the favorable results of a trial involving its phage cocktail for treating lung infections among cystic fibrosis (CF) patients, the leadership of BiomX had several critical issues to wrestle with. First, given its precarious... View Details
- November 2023
- Case
Apple Inc. in 2023
By: David B. Yoffie and Sarah von Bargen
Under CEO Tim Cook, Apple became the first trillion dollar market cap company, the first two trillion dollar company, and the first three trillion dollar company. Since the COVID pandemic, Apple gained over 20% of the world smartphone market and 50% of the U.S. market,... View Details